Antibody Testing Market Forecast to 2028

Report Code : TIPRE00016492 | Region : Global | Industry : Biotechnology | Published Date : 29/Apr/2022
Antibody Testing Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Products (Kits, Chemical & reagents, and Consumables), Indication (Pregnancy, Cardiovascular Diseases, Autoimmune Diseases, Infectious Diseases, Oncology, Endocrine Diseases, and Others), End User (Hospitals, Academic and Research Institutes, Diagnostic Laboratories, and Biopharmaceutical Companies)

The global antibody testing market was valued at US$ million 7,260.00 in 2021 and is projected to reach US$ 11,578.47 million by 2028; it is expected to grow at a CAGR of 6.9% from 2021 to 2028.

The growth of the antibody testing market is mainly attributed to factors such as rising number of Covid-19 cases worldwide, increasing prevalence of chronic diseases and growing geriatric population. However, the antibody testing market is likely to get impacted by the limitations of antibody screening tests during the forecast period.

Antibodies are immunoglobulins, Y-shaped proteins that are produced by the immune system to help stop intruders from harming the body. An antibody test is a screening for the presence of antibodies in the blood. The body makes antibodies when it fights infection, like COVID-19 or when patients get a vaccine, like a flu shot. That’s how immunity to a virus is built. These tests are also called serology tests. Antibody tests help diagnose an autoimmune disease or rule out other conditions with similar signs and symptoms. In addition, antinuclear antibodies (ANA) are a group of autoantibodies produced by an individual's immune system when it cannot adequately distinguish between "self" and "foreign" components. The global antibody testing market is driven by a rising number of COVID-19 cases worldwide, an increasing prevalence of chronic diseases, and a growing senior population. Additionally, growing government support is fueling the growth of antibody testing, which influences the development of the global antibody testing market.

Ever since severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was declared a public health emergency of international concern in late January 2020, medical professionals and researchers have been urging the need for comprehensive and rapid testing of citizens to plan measures that can contain the spread of the virus. Over time, real-time polymerase chain reaction tests and antibody tests have emerged as vital techniques for the global healthcare system to manage the outbreak. Antibody detection is essential for differential diagnosis of SARS-CoV-2. It is a test performed by patient serum or plasma with reagent red cells. Determination of specific antibodies to viral and bacterial pathogens and parasites facilitates the correct therapeutic measures to be taken. Antibody testing is critical for implementing an effective and efficient public health strategy to minimize the adverse impact of the COVID-19 pandemic. It should be adopted for important clinical utility cases and support return-to-work strategy globally.

Antibody detection kits are predictive for prognosis and detection of COVID-19 infections to assist the diseases. Since these kits help examine whether a person has developed antibodies in their bloodstream to fight the SARS-CoV-2, it indicates whether a person has been exposed to or has COVID-19. In order to manage the COVID-19 pandemic and increase patient screening, several companies are offering these rapid antibody detection kits to healthcare workers, hospitals, laboratories, and other professionals. Thus, rising incidence of coronavirus cases and growing government approvals for antibody test kits are the few factors responsible for the growth of the global antibody testing market.

COVID-19 pandemic has become the most significant challenge across the world. This challenge was frightening especially in developing countries across the globe as it will lead to reducing imports due to disruptions in global trade. Till date no definitive treatment against COVID 19 has been established. Hence, lack of definitive therapy offers significant opportunities for antibody testing market as US FDA has recently approved use of plasma therapy for critically ill COVID 19 patients. In long run antibody testing market would have significant growth prospects as many market players have received emergency use authorization for their newly developed antibody tests. All such developments would add up to the future demand for global antibody testing market.

Based on products, the global antibody testing market is segmented into kits, Chemical & Reagents, and consumables. In 2021, the kits segment accounted for the highest share of the market. Growth of this segment is attributed to the large number of manufacturers like Abbott, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Inc., and others and higher adoption of kits in various research processes. The same segment is likely to register highest CAGR in the global antibody testing market during the forecast period. Furthermore, the kits segment is sub-segmented into serological test kits, immunoglobulin kits, and lateral flow assay kits. The serological test kits held the highest market share in 2021

Global antibody testing market, based on indication, is segmented into pregnancy, cardiovascular diseases, autoimmune diseases, infectious diseases, oncology, endocrine diseases, and others. The infectious diseases segment held the largest share of the market in 2021, and same segment is anticipated to register the highest CAGR in the market during the forecast period. Growing prevalence of viral infections such as HIV and hepatitis led to the demand for the market is anticipated to grow at a substantial rate during the forecast period. The prevalence of HIV in the country has increased during recent years. As per the data provided by the US Department of Health & Human Services and supported and the Secretary’s Minority AIDS Initiative Fund (SMAIF), almost 38,700 Americans were newly infected with HIV during 2016. However, as per data obtained by the Public Health England, during 2017, around 101,600 individuals were living within the UK and the country had approximately 4,363 new cases as well as 428 AIDS-related deaths.

Global antibody testing market, based on end user, is segmented into hospitals, Academic & Research Institutes, diagnostic laboratories, and biopharmaceutical companies. The diagnostic laboratories segment held the largest share of the market in 2021, and same segment is anticipated to register the highest CAGR of 7.7 % in the market during the forecast period.

The World Health Organization (WHO), Food and Drug Administration (FDA), Centers For Disease Control And Prevention, American Heart Association, Biomedical Advanced Research and Development Authority, Foundation For Innovative New Diagnostics are some of the major primary and secondary sources referred for preparing this report.

List of Companies

1. Thermo Fisher Scientific

2. Abbott Laboratories

3. Bio-Rad Laboratories, Inc.

4. Beckton, Dickinson and Company

5. F. Hoffmann La Roche

6. Agilent Technologies

7. DiaSorin

8. Zeus Scientific

9. Abcam

10. Trinity Biotech

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Antibody Testing Market – By Products

1.3.2 Antibody Testing Market – By Indication

1.3.3 Antibody Testing Market – By End User

1.3.4 Global Antibody Testing Market – By Geography

2. Antibody Testing Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Antibody Testing Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 North America – PEST Analysis

4.2.2 Europe – PEST Analysis

4.2.3 Asia Pacific – PEST Analysis

4.2.4 Middle East & Africa – PEST Analysis

4.2.5 South & Central America– PEST Analysis

4.3 Expert Opinions

5. Antibody Testing Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Rising Number of COVID-19 Cases Worldwide

5.1.2 Increasing Prevalence of Chronic Diseases

5.1.3 Growing Geriatric Population

5.2 Market Restraints

5.2.1 Limitations of Antibody Screening Tests

5.3 Market Opportunities

5.3.1 Collaborative & Innovation-Driven Strategies

5.3.2 Growth of Healthcare Sector in Emerging Markets

5.4 Future Trends

5.4.1 Increasing Adoption and Popularity of Automation in Clinical Laboratories

5.5 Impact Analysis

6. Antibody Testing Market – Global Analysis

6.1 Global Antibody Testing Marker Revenue Forecast and Analysis

6.1.1 Global Antibody Testing Market, By Geography - Forecast And Analysis

6.1.2 Global Antibody Testing Market – Market Potential Analysis, By Region

6.1.3 Market Share Analysis of Antibody Testing Market

6.2 Company Analysis

6.2.1 Market Positioning of Key Players

6.2.2 Comparative Company Analysis

6.2.3 Growth Strategy Analysis

6.2.4 Performance Of Key Players

6.2.4.1 Thermo Fisher Scientific

6.2.4.2 F. Hoffmann La Roche

6.2.4.3 Abbott Laboratories

7. Antibody Testing Market Analysis and Forecasts to 2028 Product

7.1 Overview

7.2 Global Antibody Testing, by Products, 2021 & 2028 (% Share)

7.3 Kits

7.3.1 Overview

7.3.2 Kits: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

7.3.2.1 Serological Test Kits

7.3.2.1.1 Overview

7.3.2.1.2 Serological Test Kits: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

7.3.2.2 Immunoglobulin Kits

7.3.2.2.1 Overview

7.3.2.2.2 Immunoglobulin Kits: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

7.3.2.3 Lateral Flow Assay Kits

7.3.2.3.1 Overview

7.3.2.3.2 Lateral Flow Assay Kits: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

7.4 Chemical and Reagents

7.4.1 Overview

7.4.2 Global Chemical and Reagents Market Revenue and Forecast to 2028 (USD Million)

7.5 Consumables

7.5.1 Overview

7.5.2 Global Consumables Market Revenue and Forecast to 2028 (USD Million)

8. Antibody Testing Market Analysis – By Indication

8.1 Overview

8.2 Antibody Testing Market Revenue Share, by Indication (2021 and 2028)

8.3 Infectious Diseases

8.3.1 Overview

8.3.2 Infectious Diseases: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

8.3.2.1 Covid-19

8.3.2.1.1 Overview

8.3.2.1.2 Covid-19: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

8.3.2.2 HIV

8.3.2.2.1 Overview

8.3.2.2.2 HIV: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

8.3.2.3 Hepatitis

8.3.2.3.1 Overview

8.3.2.3.2 Hepatitis: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

8.3.2.4 Tuberculosis

8.3.2.4.1 Overview

8.3.2.4.2 Tuberculosis: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

8.3.2.5 Influenza

8.3.2.5.1 Overview

8.3.2.5.2 Influenza: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

8.3.2.6 Human Papillomavirus (HPV)

8.3.2.6.1 Overview

8.3.2.6.2 Human Papillomavirus (HPV): Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

8.3.2.7 Others

8.3.2.7.1 Overview

8.3.2.7.2 Others: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

8.4 Endocrine Diseases

8.4.1 Overview

8.4.2 Endocrine Diseases: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

8.4.2.1 Diabetes

8.4.2.1.1 Overview

8.4.2.1.2 Diabetes: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

8.4.2.2 Thyroid Disorders

8.4.2.2.1 Overview

8.4.2.2.2 Thyroid Disorders: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

8.4.2.3 Others

8.4.2.3.1 Overview

8.4.2.3.2 Others: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

8.5 Oncology

8.5.1 Overview

8.5.2 Oncology: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

8.5.2.1 Breast Cancer

8.5.2.1.1 Overview

8.5.2.1.2 Breast Cancer: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

8.5.2.2 Melanoma

8.5.2.2.1 Overview

8.5.2.2.2 Melanoma: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

8.5.2.3 Gastric Cancer

8.5.2.3.1 Overview

8.5.2.3.2 Gastric Cancer: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

8.5.2.4 Others

8.5.2.4.1 Overview

8.5.2.4.2 Others: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

8.6 Cardiovascular Diseases

8.6.1 Overview

8.6.2 Cardiovascular Diseases: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

8.7 Pregnancy

8.7.1 Overview

8.7.2 Pregnancy: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

8.8 Autoimmune Diseases

8.8.1 Overview

8.8.2 Autoimmune Diseases: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

8.8.2.1 Rheumatoid Arthritis

8.8.2.1.1 Overview

8.8.2.1.2 Rheumatoid Arthritis: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

8.8.2.2 Inflammatory Bowel Disease

8.8.2.2.1 Overview

8.8.2.2.2 Inflammatory Bowel Disease: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

8.8.2.3 Multiple Sclerosis

8.8.2.3.1 Overview

8.8.2.3.2 Multiple Sclerosis: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

8.8.2.4 Others

8.8.2.4.1 Overview

8.8.2.4.2 Others: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

8.9 Other Diseases

8.9.1 Overview

8.9.2 Other Diseases: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

9. Antibody Testing Market – By End User

9.1 Overview

9.2 Antibody Testing Market, by End User, 2021 and 2028 (%)

9.3 Diagnostic Laboratories

9.3.1 Overview

9.3.2 Global Diagnostic Laboratories Market Revenue and Forecast to 2028 (USD Million)

9.4 Hospitals

9.4.1 Overview

9.4.2 Global Hospitals Market Revenue and Forecast to 2028 (USD Million)

9.5 Biopharmaceutical Companies

9.5.1 Overview

9.5.2 Biopharmaceutical Companies: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

9.6 Academic Research Institutes

9.6.1 Overview

9.6.2 Academic Research Institutes: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

10. Antibody Testing Market Analysis and Forecasts To 2028 Geographical Analysis

10.1 North America: Antibody Testing Market

10.1.1 Overview

10.1.2 North America: Antibody Testing Market, - Revenue and Forecast to 2028 (USD Million)

10.1.3 North America: Antibody Testing Market, by Products– Revenue and Forecast to 2028 (USD Million)

10.1.3.1 North America: Antibody Testing Market, by Kits – Revenue and Forecast to 2028 (USD Million)

10.1.4 North America: Antibody Testing Market, by Indication – Revenue and Forecast to 2028 (USD Million)

10.1.4.1 North America: Antibody Testing Market, by Infectious Diseases– Revenue and Forecast to 2028 (USD Million)

10.1.4.2 North America: Antibody Testing Market, by Endocrine Diseases – Revenue and Forecast to 2028 (USD Million)

10.1.4.3 North America: Antibody Testing Market, by Oncology – Revenue and Forecast to 2028 (USD Million)

10.1.4.4 North America: Antibody Testing Market, by Autoimmune Diseases – Revenue and Forecast to 2028 (USD Million)

10.1.5 North America: Antibody Testing Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.6 North America: Antibody Testing Market, by Country, 2021 & 2028 (%)

10.1.7 US: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

10.1.7.1 US: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

10.1.7.2 US: Antibody Testing Market, by Products – Revenue and Forecast to 2028 (USD Million)

10.1.7.2.1 US: Antibody Testing Market, by Kits – Revenue and Forecast to 2028 (USD Million)

10.1.7.3 US: Antibody Testing Market, by Indication – Revenue and Forecast to 2028 (USD Million)

10.1.7.3.1 US: Antibody Testing Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)

10.1.7.3.2 US: Antibody Testing Market, by Endocrine Diseases – Revenue and Forecast to 2028 (USD Million)

10.1.7.3.3 US: Antibody Testing Market, by Oncology – Revenue and Forecast to 2028 (USD Million)

10.1.7.3.4 US: Antibody Testing Market, by Autoimmune Diseases – Revenue and Forecast to 2028 (USD Million)

10.1.7.4 US: Antibody Testing Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.8 Canada: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

10.1.8.1 Canada: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

10.1.8.2 Canada: Antibody Testing Market, by Products – Revenue and Forecast to 2028 (USD Million)

10.1.8.2.1 Canada: Antibody Testing Market, by Kits – Revenue and Forecast to 2028 (USD Million)

10.1.8.3 Canada: Antibody Testing Market, by Indication – Revenue and Forecast to 2028 (USD Million)

10.1.8.3.1 Canada: Antibody Testing Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)

10.1.8.3.2 Canada: Antibody Testing Market, by Endocrine Diseases – Revenue and Forecast to 2028 (USD Million)

10.1.8.3.3 Canada: Antibody Testing Market, by Oncology – Revenue and Forecast to 2028 (USD Million)

10.1.8.3.4 Canada: Antibody Testing Market, by Autoimmune Diseases – Revenue and Forecast to 2028 (USD Million)

10.1.8.4 Canada: Antibody Testing Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.9 Mexico: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

10.1.9.1 Mexico: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

10.1.9.2 Mexico: Antibody Testing Market, by Products – Revenue and Forecast to 2028 (USD Million)

10.1.9.3 Mexico: Antibody Testing Market, by Kits – Revenue and Forecast to 2028 (USD Million)

10.1.9.4 Mexico: Antibody Testing Market, by Indication – Revenue and Forecast to 2028 (USD Million)

10.1.9.4.1 Mexico: Antibody Testing Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)

10.1.9.4.2 Mexico: Antibody Testing Market, by Endocrine Diseases – Revenue and Forecast to 2028 (USD Million)

10.1.9.4.3 Mexico: Antibody Testing Market, by Oncology – Revenue and Forecast to 2028 (USD Million)

10.1.9.4.4 Mexico: Antibody Testing Market, by Autoimmune Diseases – Revenue and Forecast to 2028 (USD Million)

10.1.9.5 Mexico: Antibody Testing Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.2 Europe: Antibody Testing Market

10.2.1 Overview

10.2.2 Europe: Antibody Testing Market - Revenue and Forecast to 2028 (USD Million)

10.2.3 Europe: Antibody Testing Market, by Products – Revenue and Forecast to 2028(USD Million)

10.2.3.1 Europe: Antibody Testing Market, by Kits – Revenue and Forecast to 2028 (USD Million)

10.2.4 Europe: Antibody Testing Market, by Indication – Revenue and Forecast to 2028 (USD Million)

10.2.4.1 Europe: Antibody Testing Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)

10.2.4.2 Europe: Antibody Testing Market, by Endocrine Diseases – Revenue and Forecast to 2028 (USD Million)

10.2.4.3 Europe: Antibody Testing Market, by Oncology – Revenue and Forecast to 2028 (USD Million)

10.2.4.4 Europe: Antibody Testing Market, by Autoimmune Diseases – Revenue and Forecast to 2028 (USD Million)

10.2.5 Europe: Antibody Testing Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.2.6 Europe: Antibody Testing Market, by Country, 2021 & 2028 (%)

10.2.7 Germany: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

10.2.7.1 Germany: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

10.2.7.2 Germany: Antibody Testing Market, by Products – Revenue and Forecast to 2028 (USD Million)

10.2.7.2.1 Germany: Antibody Testing Market, by Kits – Revenue and Forecast to 2028 (USD Million)

10.2.7.3 Germany: Antibody Testing Market, by Indication – Revenue and Forecast to 2028 (USD Million)

10.2.7.3.1 Germany: Antibody Testing Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)

10.2.7.3.2 Germany: Antibody Testing Market, by Endocrine Diseases – Revenue and Forecast to 2028 (USD Million)

10.2.7.3.3 Germany: Antibody Testing Market, by Oncology – Revenue and Forecast to 2028 (USD Million)

10.2.7.3.4 Germany: Antibody Testing Market, by Autoimmune Diseases – Revenue and Forecast to 2028 (USD Million)

10.2.7.4 Germany: Antibody Testing Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.2.8 UK: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

10.2.8.1 UK: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

10.2.8.2 UK: Antibody Testing Market, by Products – Revenue and Forecast to 2028 (USD Million)

10.2.8.2.1 UK: Antibody Testing Market, by Kits – Revenue and Forecast to 2028 (USD Million)

10.2.8.3 UK: Antibody Testing Market, by Indication – Revenue and Forecast to 2028 (USD Million)

10.2.8.3.1 UK: Antibody Testing Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)

10.2.8.3.2 UK: Antibody Testing Market, by Endocrine Diseases – Revenue and Forecast to 2028 (USD Million)

10.2.8.3.3 UK: Antibody Testing Market, by Oncology – Revenue and Forecast to 2028 (USD Million)

10.2.8.3.4 UK: Antibody Testing Market, by Autoimmune Diseases – Revenue and Forecast to 2028 (USD Million)

10.2.8.4 UK: Antibody Testing Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.2.9 France: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

10.2.9.1 France: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

10.2.9.2 France: Antibody Testing Market, by Products – Revenue and Forecast to 2028 (USD Million)

10.2.9.2.1 France: Antibody Testing Market, by Kits – Revenue and Forecast to 2028 (USD Million)

10.2.9.3 France: Antibody Testing Market, by Indication – Revenue and Forecast to 2028 (USD Million)

10.2.9.3.1 France: Antibody Testing Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)

10.2.9.3.2 France: Antibody Testing Market, by Endocrine Diseases – Revenue and Forecast to 2028 (USD Million)

10.2.9.3.3 France: Antibody Testing Market, by Oncology – Revenue and Forecast to 2028 (USD Million)

10.2.9.3.4 France: Antibody Testing Market, by Autoimmune Diseases – Revenue and Forecast to 2028 (USD Million)

10.2.9.4 France: Antibody Testing Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.2.10 Spain: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

10.2.10.1 Spain: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

10.2.10.2 Spain: Antibody Testing Market, by Products – Revenue and Forecast to 2028 (USD Million)

10.2.10.2.1 Spain: Antibody Testing Market, by Kits – Revenue and Forecast to 2028 (USD Million)

10.2.10.3 Spain: Antibody Testing Market, by Indication – Revenue and Forecast to 2028 (USD Million)

10.2.10.3.1 Spain: Antibody Testing Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)

10.2.10.3.2 Spain: Antibody Testing Market, by Endocrine Diseases – Revenue and Forecast to 2028 (USD Million)

10.2.10.3.3 Spain: Antibody Testing Market, by Oncology – Revenue and Forecast to 2028 (USD Million)

10.2.10.3.4 Spain: Antibody Testing Market, by Autoimmune Diseases – Revenue and Forecast to 2028 (USD Million)

10.2.10.4 Spain: Antibody Testing Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.2.11 Italy: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

10.2.11.1 Italy: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

10.2.11.2 Italy: Antibody Testing Market, by Products – Revenue and Forecast to 2028 (USD Million)

10.2.11.2.1 Italy: Antibody Testing Market, by Kits – Revenue and Forecast to 2028 (USD Million)

10.2.11.3 Italy: Antibody Testing Market, by Indication – Revenue and Forecast to 2028 (USD Million)

10.2.11.3.1 Italy: Antibody Testing Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)

10.2.11.3.2 Italy: Antibody Testing Market, by Endocrine Diseases – Revenue and Forecast to 2028 (USD Million)

10.2.11.3.3 Italy: Antibody Testing Market, by Oncology – Revenue and Forecast to 2028 (USD Million)

10.2.11.3.4 Italy: Antibody Testing Market, by Autoimmune Diseases – Revenue and Forecast to 2028 (USD Million)

10.2.11.4 Italy: Antibody Testing Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.2.12 Greece: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

10.2.12.1 Greece: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

10.2.12.2 Greece: Antibody Testing Market, by Products – Revenue and Forecast to 2028 (USD Million)

10.2.12.2.1 Greece: Antibody Testing Market, by Kits – Revenue and Forecast to 2028 (USD Million)

10.2.12.3 Greece: Antibody Testing Market, by Indication – Revenue and Forecast to 2028 (USD Million)

10.2.12.3.1 Greece: Antibody Testing Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)

10.2.12.3.2 Greece: Antibody Testing Market, by Endocrine Diseases – Revenue and Forecast to 2028 (USD Million)

10.2.12.3.3 Greece: Antibody Testing Market, by Oncology – Revenue and Forecast to 2028 (USD Million)

10.2.12.3.4 Greece: Antibody Testing Market, by Autoimmune Diseases – Revenue and Forecast to 2028 (USD Million)

10.2.12.4 Greece: Antibody Testing Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.2.13 Rest of Europe: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

10.2.13.1 Rest of Europe: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

10.2.13.2 Rest of Europe: Antibody Testing Market, by Products – Revenue and Forecast to 2028 (USD Million)

10.2.13.2.1 Rest of Europe: Antibody Testing Market, by Kits – Revenue and Forecast to 2028 (USD Million)

10.2.13.3 Rest of Europe: Antibody Testing Market, by Indication – Revenue and Forecast to 2028 (USD Million)

10.2.13.3.1 Rest of Europe: Antibody Testing Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)

10.2.13.3.2 Rest of Europe: Antibody Testing Market, by Endocrine Diseases – Revenue and Forecast to 2028 (USD Million)

10.2.13.3.3 Rest of Europe: Antibody Testing Market, by Oncology – Revenue and Forecast to 2028 (USD Million)

10.2.13.3.4 Rest of Europe: Antibody Testing Market, by Autoimmune Diseases – Revenue and Forecast to 2028 (USD Million)

10.2.13.4 Rest of Europe: Antibody Testing Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.3 Asia Pacific: Antibody Testing Market

10.3.1 Overview

10.3.2 Asia Pacific: Antibody Testing Market - Revenue and Forecast to 2028 (USD Million)

LIST OF TABLES.

Table 1. Total Number of Persons Aged 60 Years or Above – by Region, 2017 & 2050

Table 2. North America: Antibody Testing Market, by Products – Revenue and Forecast to 2028 (USD Million)

Table 3. North America: Antibody Testing Market, by Kits – Revenue and Forecast to 2028 (USD Million)

Table 4. North America: Antibody Testing Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 5. North America: Antibody Testing Market, by Infectious Diseases– Revenue and Forecast to 2028 (USD Million)

Table 6. North America: Antibody Testing Market, by Endocrine Diseases – Revenue and Forecast to 2028 (USD Million)

Table 7. North America: Antibody Testing Market, by Oncology – Revenue and Forecast to 2028 (USD Million)

Table 8. North America: Antibody Testing Market, by Autoimmune Diseases – Revenue and Forecast to 2028 (USD Million)

Table 9. North America: Antibody Testing Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 10. US: Antibody Testing Market, by Products – Revenue and Forecast to 2028 (USD Million)

Table 11. US: Antibody Testing Market, by Kits – Revenue and Forecast to 2028 (USD Million)

Table 12. US: Antibody Testing Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 13. US: Antibody Testing Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)

Table 14. US: Antibody Testing Market, by Endocrine Diseases – Revenue and Forecast to 2028 (USD Million)

Table 15. US: Antibody Testing Market, by Oncology – Revenue and Forecast to 2028 (USD Million)

Table 16. US: Antibody Testing Market, by Autoimmune Diseases – Revenue and Forecast to 2028 (USD Million)

Table 17. US: Antibody Testing Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 18. Canada: Antibody Testing Market, by Products – Revenue and Forecast to 2028 (USD Million)

Table 19. Canada: Antibody Testing Market, by Kits – Revenue and Forecast to 2028 (USD Million)

Table 20. Canada: Antibody Testing Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 21. Canada: Antibody Testing Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)

Table 22. Canada: Antibody Testing Market, by Endocrine Diseases – Revenue and Forecast to 2028 (USD Million)

Table 23. Canada: Antibody Testing Market, by Oncology – Revenue and Forecast to 2028 (USD Million)

Table 24. Canada: Antibody Testing Market, by Autoimmune Diseases – Revenue and Forecast to 2028 (USD Million)

Table 25. Canada: Antibody Testing Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 26. Mexico: Antibody Testing Market, by Products – Revenue and Forecast to 2028 (USD Million)

Table 27. Mexico: Antibody Testing Market, by Kits – Revenue and Forecast to 2028 (USD Million)

Table 28. Mexico: Antibody Testing Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 29. Mexico: Antibody Testing Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)

Table 30. Mexico: Antibody Testing Market, by Endocrine Diseases – Revenue and Forecast to 2028 (USD Million)

Table 31. Mexico: Antibody Testing Market, by Oncology – Revenue and Forecast to 2028 (USD Million)

Table 32. Mexico: Antibody Testing Market, by Autoimmune Diseases – Revenue and Forecast to 2028 (USD Million)

Table 33. Mexico: Antibody Testing Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 34. Europe: Antibody Testing Market, by Products– Revenue and Forecast to 2028 (USD Million)

Table 35. Europe: Antibody Testing Market, by Kits – Revenue and Forecast to 2028 (USD Million)

Table 36. Europe: Antibody Testing Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 37. Europe: Antibody Testing Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)

Table 38. Europe: Antibody Testing Market, by Endocrine Diseases – Revenue and Forecast to 2028 (USD Million)

Table 39. Europe: Antibody Testing Market, by Oncology – Revenue and Forecast to 2028 (USD Million)

Table 40. Europe: Antibody Testing Market, by Autoimmune Diseases – Revenue and Forecast to 2028 (USD Million)

Table 41. Europe: Antibody Testing Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 42. Prevalence of Diabetes and Related Risk Factors in Germany 139

Table 43. Germany: Antibody Testing Market, by Products– Revenue and Forecast to 2028 (USD Million)

Table 44. Germany: Antibody Testing Market, by Kits – Revenue and Forecast to 2028 (USD Million)

Table 45. Germany: Antibody Testing Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 46. Germany: Antibody Testing Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)

Table 47. Germany: Antibody Testing Market, by Endocrine Diseases – Revenue and Forecast to 2028 (USD Million)

Table 48. Germany: Antibody Testing Market, by Oncology – Revenue and Forecast to 2028 (USD Million)

Table 49. Germany: Antibody Testing Market, by Autoimmune Diseases – Revenue and Forecast to 2028 (USD Million)

Table 50. Germany: Antibody Testing Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 51. Cancer Statistics for the UK

Table 52. UK: Antibody Testing Market, by Products– Revenue and Forecast to 2028 (USD Million)

Table 53. UK: Antibody Testing Market, by Kits – Revenue and Forecast to 2028 (USD Million)

Table 54. UK: Antibody Testing Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 55. UK: Antibody Testing Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)

Table 56. UK: Antibody Testing Market, by Endocrine Diseases – Revenue and Forecast to 2028 (USD Million)

Table 57. UK: Antibody Testing Market, by Oncology – Revenue and Forecast to 2028 (USD Million)

Table 58. UK: Antibody Testing Market, by Autoimmune Diseases – Revenue and Forecast to 2028 (USD Million)

Table 59. UK: Antibody Testing Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 60. France: Antibody Testing Market, by Products– Revenue and Forecast to 2028 (USD Million)

Table 61. France: Antibody Testing Market, by Kits – Revenue and Forecast to 2028 (USD Million)

Table 62. France: Antibody Testing Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 63. France: Antibody Testing Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)

Table 64. France: Antibody Testing Market, by Endocrine Diseases – Revenue and Forecast to 2028 (USD Million)

Table 65. France: Antibody Testing Market, by Oncology – Revenue and Forecast to 2028 (USD Million)

Table 66. France: Antibody Testing Market, by Autoimmune Diseases – Revenue and Forecast to 2028 (USD Million)

Table 67. France: Antibody Testing Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 68. Spain: Antibody Testing Market, by Products– Revenue and Forecast to 2028 (USD Million)

Table 69. Spain: Antibody Testing Market, by Kits – Revenue and Forecast to 2028 (USD Million)

Table 70. Spain: Antibody Testing Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 71. Spain: Antibody Testing Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)

Table 72. Spain: Antibody Testing Market, by Endocrine Diseases – Revenue and Forecast to 2028 (USD Million)

Table 73. Spain: Antibody Testing Market, by Oncology – Revenue and Forecast to 2028 (USD Million)

Table 74. Spain: Antibody Testing Market, by Autoimmune Diseases – Revenue and Forecast to 2028 (USD Million)

Table 75. Spain: Antibody Testing Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 76. Italy: Antibody Testing Market, by Products– Revenue and Forecast to 2028 (USD Million)

Table 77. Italy: Antibody Testing Market, by Kits – Revenue and Forecast to 2028 (USD Million)

Table 78. Italy: Antibody Testing Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 79. Italy: Antibody Testing Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)

Table 80. Italy: Antibody Testing Market, by Endocrine Diseases – Revenue and Forecast to 2028 (USD Million)

Table 81. Italy: Antibody Testing Market, by Oncology – Revenue and Forecast to 2028 (USD Million)

Table 82. Italy: Antibody Testing Market, by Autoimmune Diseases – Revenue and Forecast to 2028 (USD Million)

Table 83. Italy: Antibody Testing Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 84. Greece: Antibody Testing Market, by Products– Revenue and Forecast to 2028 (USD Million)

Table 85. Greece: Antibody Testing Market, by Kits – Revenue and Forecast to 2028 (USD Million)

Table 86. Greece: Antibody Testing Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 87. Greece: Antibody Testing Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)

Table 88. Greece: Antibody Testing Market, by Endocrine Diseases – Revenue and Forecast to 2028 (USD Million)

Table 89. Greece: Antibody Testing Market, by Oncology – Revenue and Forecast to 2028 (USD Million)

Table 90. Greece: Antibody Testing Market, by Autoimmune Diseases – Revenue and Forecast to 2028 (USD Million)

Table 91. Greece: Antibody Testing Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 92. Rest of Europe: Antibody Testing Market, by Products– Revenue and Forecast to 2028 (USD Million)

Table 93. Rest of Europe: Antibody Testing Market, by Kits – Revenue and Forecast to 2028 (USD Million)

Table 94. Rest of Europe: Antibody Testing Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 95. Rest of Europe: Antibody Testing Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)

Table 96. Rest of Europe: Antibody Testing Market, by Endocrine Diseases – Revenue and Forecast to 2028 (USD Million)

Table 97. Rest of Europe: Antibody Testing Market, by Oncology – Revenue and Forecast to 2028 (USD Million)

Table 98. Rest of Europe: Antibody Testing Market, by Autoimmune Diseases – Revenue and Forecast to 2028 (USD Million)

Table 99. Rest of Europe: Antibody Testing Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 100. Asia-Pacific: Antibody Testing Market, by Products– Revenue and Forecast to 2028 (USD Million)

Table 101. Asia-Pacific: Antibody Testing Market, by Kits – Revenue and Forecast to 2028 (USD Million)

Table 102. Asia-Pacific: Antibody Testing Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 103. Asia-Pacific: Antibody Testing Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)

Table 104. Asia-Pacific: Antibody Testing Market, by Endocrine Diseases – Revenue and Forecast to 2028 (USD Million)

Table 105. Asia-Pacific: Antibody Testing Market, by Oncology – Revenue and Forecast to 2028 (USD Million)

Table 106. Asia-Pacific: Antibody Testing Market, by Autoimmune Diseases – Revenue and Forecast to 2028 (USD Million)

Table 107. Asia-Pacific: Antibody Testing Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 108. Incidence rate of cancer in 2020 in China

Table 109. China: Antibody Testing Market, by Products– Revenue and Forecast to 2028 (USD Million)

Table 110. China: Antibody Testing Market, by Kits – Revenue and Forecast to 2028 (USD Million)

Table . China: Antibody Testing Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table . China: Antibody Testing Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)

Table . China: Antibody Testing Market, by Endocrine Diseases – Revenue and Forecast to 2028 (USD Million)

Table . China: Antibody Testing Market, by Oncology – Revenue and Forecast to 2028 (USD Million)

Table . China: Antibody Testing Market, by Autoimmune Diseases – Revenue and Forecast to 2028 (USD Million)

Table . China: Antibody Testing Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table . Japan: Antibody Testing Market, by Products– Revenue and Forecast to 2028 (USD Million)

Table . Japan: Antibody Testing Market, by Kits – Revenue and Forecast to 2028 (USD Million)

Table . Japan: Antibody Testing Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table . Japan: Antibody Testing Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)

Table . Japan: Antibody Testing Market, by Endocrine Diseases – Revenue and Forecast to 2028 (USD Million)

Table . Japan: Antibody Testing Market, by Oncology – Revenue and Forecast to 2028 (USD Million)

Table . Japan: Antibody Testing Market, by Autoimmune Diseases – Revenue and Forecast to 2028 (USD Million)

Table . Japan: Antibody Testing Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table . India: Antibody Testing Market, by Products– Revenue and Forecast to 2028 (USD Million)

Table . India: Antibody Testing Market, by Kits – Revenue and Forecast to 2028 (USD Million)

Table . India: Antibody Testing Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table . India: Antibody Testing Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)

Table . India: Antibody Testing Market, by Endocrine Diseases – Revenue and Forecast to 2028 (USD Million)

Table . India: Antibody Testing Market, by Oncology – Revenue and Forecast to 2028 (USD Million)

Table . India: Antibody Testing Market, by Autoimmune Diseases – Revenue and Forecast to 2028 (USD Million)

Table . India: Antibody Testing Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table . South Korea: Antibody Testing Market, by Products– Revenue and Forecast to 2028 (USD Million)

Table . South Korea: Antibody Market, by Kits – Revenue and Forecast to 2028 (USD Million)

Table . South Korea: Antibody Testing Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table . South Korea: Antibody Testing Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)

Table . South Korea: Antibody Testing Market, by Endocrine Diseases – Revenue and Forecast to 2028 (USD Million)

Table . South Korea: Antibody Testing Market, by Oncology – Revenue and Forecast to 2028 (USD Million)

Table 139. South Korea: Antibody Testing Market, by Autoimmune Diseases – Revenue and Forecast to 2028 (USD Million)

Table 140. South Korea: Antibody Testing Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 141. Australia: Antibody Testing Market, by Products– Revenue and Forecast to 2028 (USD Million)

Table 142. Australia: Antibody Testing Market, by Kits – Revenue and Forecast to 2028 (USD Million)

Table 143. Australia: Antibody Testing Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 144. Australia: Antibody Testing Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)

Table 145. Australia: Antibody Testing Market, by Endocrine Diseases – Revenue and Forecast to 2028 (USD Million)

Table 146. Australia: Antibody Testing Market, by Oncology – Revenue and Forecast to 2028 (USD Million)

Table 147. Australia: Antibody Testing Market, by Autoimmune Diseases – Revenue and Forecast to 2028 (USD Million)

Table 148. Australia: Antibody Testing Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 149. Rest of Asia Pacific: Antibody Testing Market, by Products– Revenue and Forecast to 2028 (USD Million)

Table 150. Rest of Asia Pacific: Antibody Testing Market, by Kits – Revenue and Forecast to 2028 (USD Million)

Table 151. Rest of Asia Pacific: Antibody Testing Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 152. Rest of Asia Pacific: Antibody Testing Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)

Table 153. Rest of Asia Pacific: Antibody Testing Market, by Endocrine Diseases – Revenue and Forecast to 2028 (USD Million)

Table 154. Rest of Asia Pacific: Antibody Testing Market, by Oncology – Revenue and Forecast to 2028 (USD Million)

Table 155. Rest of Asia Pacific: Antibody Testing Market, by Autoimmune Diseases – Revenue and Forecast to 2028 (USD Million)

Table 156. Rest of Asia Pacific: Antibody Testing Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 157. Middle East & Africa Antibody Testing Market, by Products – Revenue and Forecast to 2028 (USD Million)

Table 158. Middle East & Africa: Antibody Testing Market, by Kits – Revenue and Forecast to 2028 (USD Million)

Table 159. Middle East & Africa Antibody Testing Market, by Indication - Revenue and Forecast to 2028 (USD Million)

Table 160. Middle East & Africa: Antibody Testing Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)

Table 161. Middle East & Africa: Antibody Testing Market, by Endocrine Diseases – Revenue and Forecast to 2028 (USD Million)

Table 162. Middle East & Africa: Antibody Testing Market, by Oncology – Revenue and Forecast to 2028 (USD Million)

Table 163. Middle East & Africa: Antibody Testing Market, by Autoimmune Diseases – Revenue and Forecast to 2028 (USD Million)

Table 164. Middle East & Africa Antibody Testing Market, by End User - Revenue and Forecast to 2028 (USD Million)

Table 165. Saudi Arabia Antibody Testing Market, by Products – Revenue and Forecast to 2028 (USD Million)

Table 166. Saudi Arabia: Antibody Testing Market, by Kits – Revenue and Forecast to 2028 (USD Million)

Table 167. Saudi Arabia Antibody Testing Market, by Indication - Revenue and Forecast to 2028 (USD Million)

Table 168. Saudi Arabia: Antibody Testing Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)

Table 169. Saudi Arabia: Antibody Testing Market, by Endocrine Diseases – Revenue and Forecast to 2028 (USD Million)

Table 170. Saudi Arabia: Antibody Testing Market, by Oncology – Revenue and Forecast to 2028 (USD Million)

Table 171. Saudi Arabia: Antibody Testing Market, by Autoimmune Diseases – Revenue and Forecast to 2028 (USD Million)

Table 172. Saudi Arabia Antibody Testing Market, by End User - Revenue and Forecast to 2028 (USD Million)

Table 173. UAE: Antibody Testing Market, by Products – Revenue and Forecast to 2028 (USD Million)

Table 174. UAE: Antibody Testing Market, by Kits – Revenue and Forecast to 2028 (USD Million)

Table 175. UAE: Antibody Testing Market, by Indication - Revenue and Forecast to 2028 (USD Million)

Table 176. UAE: Antibody Testing Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)

Table 177. UAE: Antibody Testing Market, by Endocrine Diseases – Revenue and Forecast to 2028 (USD Million)

Table 178. UAE: Antibody Testing Market, by Oncology – Revenue and Forecast to 2028 (USD Million)

Table 179. UAE: Antibody Testing Market, by Autoimmune Diseases – Revenue and Forecast to 2028 (USD Million)

Table 180. UAE: Antibody Testing Market, by End User - Revenue and Forecast to 2028 (USD Million)

Table 181. South Africa Antibody Testing Market, by Products – Revenue and Forecast to 2028 (USD Million)

Table 182. South Africa: Antibody Testing Market, by Kits – Revenue and Forecast to 2028 (USD Million)

Table 183. South Africa Antibody Testing Market, by Indication - Revenue and Forecast to 2028 (USD Million)

Table 184. South Africa: Antibody Testing Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)

Table 185. South Africa: Antibody Testing Market, by Endocrine Diseases – Revenue and Forecast to 2028 (USD Million)

Table 186. South Africa: Antibody Testing Market, by Oncology – Revenue and Forecast to 2028 (USD Million)

Table 187. South Africa: Antibody Testing Market, by Autoimmune Diseases – Revenue and Forecast to 2028 (USD Million)

Table 188. South Africa Antibody Testing Market, by End User - Revenue and Forecast to 2028 (USD Million)

Table 189. Rest of Middle East & Africa: Antibody Testing Market, by Products – Revenue and Forecast to 2028 (USD Million)

Table 190. Rest of Middle East & Africa: Antibody Testing Market, by Kits – Revenue and Forecast to 2028 (USD Million)

Table 191. Rest of Middle East & Africa: Antibody Testing Market, by Indication - Revenue and Forecast to 2028 (USD Million)

Table 192. Rest of Middle East & Africa: Antibody Testing Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)

Table 193. Rest of Middle East & Africa: Antibody Testing Market, by Endocrine Diseases – Revenue and Forecast to 2028 (USD Million)

Table 194. Rest of Middle East & Africa: Antibody Testing Market, by Oncology – Revenue and Forecast to 2028 (USD Million)

Table 195. Rest of Middle East & Africa: Antibody Testing Market, by Autoimmune Diseases – Revenue and Forecast to 2028 (USD Million)

Table 196. Rest of Middle East & Africa: Antibody Testing Market, by End User - Revenue and Forecast to 2028 (USD Million)

Table 197. South & Central America: Antibody Testing Market, by Products – Revenue and Forecast to 2028 (USD Million)

Table 198. South & Central America: Antibody Testing Market, by Kits – Revenue and Forecast to 2028 (USD Million)

Table 199. South & Central America: Antibody Testing Market, by Indication- Revenue and Forecast to 2028 (USD Million)

Table 200. South & Central America: Antibody Testing Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)

Table 201. South & Central America: Antibody Testing Market, by Endocrine Diseases – Revenue and Forecast to 2028 (USD Million)

Table 202. South and Central America: Antibody Testing Market, by Oncology – Revenue and Forecast to 2028 (USD Million)

Table 203. South & Central America: Antibody Testing Market, by Autoimmune Diseases – Revenue and Forecast to 2028 (USD Million)

Table 204. South & Central America: Antibody Testing Market, by End User - Revenue and Forecast to 2028 (USD Million)

Table 205. Brazil: Antibody Testing Market, by Products – Revenue and Forecast to 2028 (USD Million)

Table 206. Brazil: Antibody Testing Market, by Kits – Revenue and Forecast to 2028 (USD Million)

Table 207. Brazil: Antibody Testing Market, by Indication- Revenue and Forecast to 2028 (USD Million)

Table 208. Brazil: Antibody Testing Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)

Table 209. Brazil: Antibody Testing Market, by Endocrine Diseases – Revenue and Forecast to 2028 (USD Million)

Table 210. Brazil: Antibody Testing Market, by Oncology – Revenue and Forecast to 2028 (USD Million)

Table 211. Brazil: Antibody Testing Market, by Autoimmune Diseases – Revenue and Forecast to 2028 (USD Million)

Table 212. Brazil: Antibody Testing Market, by End User - Revenue and Forecast to 2028 (USD Million)

Table 213. Argentina: Antibody Testing Market, by Products – Revenue and Forecast to 2028 (USD Million)

Table 214. Argentina: Antibody Testing Market, by Kits – Revenue and Forecast to 2028 (USD Million)

Table 215. Argentina: Antibody Testing Market, by Indication- Revenue and Forecast to 2028 (USD Million)

Table 216. Argentina: Antibody Testing Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)

Table 217. Argentina: Antibody Testing Market, by Endocrine Diseases – Revenue and Forecast to 2028 (USD Million)

Table 218. Argentina: Antibody Testing Market, by Oncology – Revenue and Forecast to 2028 (USD Million)

Table 219. Argentina: Antibody Testing Market, by Autoimmune Diseases – Revenue and Forecast to 2028 (USD Million)

Table 220. Argentina: Antibody Testing Market, by End User - Revenue and Forecast to 2028 (USD Million)

Table 221. Rest of South & Central America: Antibody Testing Market, by Products – Revenue and Forecast to 2028 (USD Million)

Table 222. Rest of South & Central America: Antibody Testing Market, by Kits – Revenue and Forecast to 2028 (USD Million)

Table 223. Rest of South & Central America: Antibody Testing Market, by Indication- Revenue and Forecast to 2028 (USD Million)

Table 224. Rest of South & Central America: Antibody Testing Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)

Table 225. Rest of South & Central America: Antibody Testing Market, by Endocrine Diseases – Revenue and Forecast to 2028 (USD Million)

Table 226. Rest of South & Central America: Antibody Testing Market, by Oncology – Revenue and Forecast to 2028 (USD Million)

Table 227. Rest of South & Central America: Antibody Testing Market, by Autoimmune Diseases – Revenue and Forecast to 2028 (USD Million)

Table 228. Rest of South & Central America: Antibody Testing Market, by End User - Revenue and Forecast to 2028 (USD Million)

Table 229. Organic Developments Done By Companies

Table 230. Inorganic Developments Done By Companies

Table 231. Glossary of Terms, Antibody Testing Market

List of Companies

1. Thermo Fisher Scientific

2. Abbott Laboratories

3. Bio-Rad Laboratories, Inc.

4. Beckton, Dickinson and Company

5. F. Hoffmann La Roche

6. Agilent Technologies

7. DiaSorin

8. Zeus Scientific

9. Abcam

10. Trinity Biotech

Reason To Buy

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the antibody testing market.

• Highlights key business priorities in order to assist companies to realign their business strategies.

• The key findings and recommendations highlight crucial progressive industry trends in the global antibody testing market, thereby allowing players across the value chain to develop effective long-term strategies.

• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

• Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

AVAILABLE CUSTOMIZATION RESEARCH METHODOLOGY REQUEST FOR TOC FREE SAMPLE REPORT
CHOOSE LICENCE TYPE
(Antibody Testing Market Forecast to 2028 )
  • Single User Price $4,550$3,640
  • Site Price $6,550$5,240
  • Enterprise Price $8,550$6,840
Buy Now Add to Cart
REQUEST FOR TOC
SPEAK TO ANALYST
FREE SAMPLE
REPORT
INQUIRE BEFORE
BUYING
TOP
Quick Enquiry